vs
Simulations Plus, Inc.（SLP）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Simulations Plus, Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.6倍（$18.4M vs $11.6M），Simulations Plus, Inc.同比增速更快（-2.7% vs -21.4%），过去两年Simulations Plus, Inc.的营收复合增速更高（0.3% vs -5.4%）
Simulations Plus公司为医药生物、化工、化妆品、食品原料及除草剂领域开发ADMET（吸收、分布、代谢、排泄和毒性）建模仿真软件，并于2014年9月收购了提供临床试验数据分析及咨询服务的Cognigen公司，助力相关行业研发工作开展。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
SLP vs STRO — 直观对比
营收规模更大
SLP
是对方的1.6倍
$11.6M
营收增速更快
SLP
高出18.7%
-21.4%
两年增速更快
SLP
近两年复合增速
-5.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.4M | $11.6M |
| 净利润 | $676.0K | — |
| 毛利率 | 59.1% | — |
| 营业利润率 | 3.9% | — |
| 净利率 | 3.7% | — |
| 营收同比 | -2.7% | -21.4% |
| 净利润同比 | 228.2% | 35.4% |
| 每股收益（稀释后） | $0.03 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLPSTRO
| Q4 25 | $18.4M | $11.6M | ||
| Q3 25 | $17.5M | $9.7M | ||
| Q2 25 | $20.4M | $63.7M | ||
| Q1 25 | $22.4M | $17.4M | ||
| Q4 24 | $18.9M | $14.8M | ||
| Q3 24 | $18.7M | $8.5M | ||
| Q2 24 | $18.5M | $25.7M | ||
| Q1 24 | $18.3M | $13.0M |
净利润SLPSTRO
| Q4 25 | $676.0K | — | ||
| Q3 25 | $-681.0K | $-56.9M | ||
| Q2 25 | $-67.3M | $-11.5M | ||
| Q1 25 | $3.1M | $-76.0M | ||
| Q4 24 | $206.0K | $-72.4M | ||
| Q3 24 | $843.0K | $-48.8M | ||
| Q2 24 | $3.1M | $-48.0M | ||
| Q1 24 | $4.0M | $-58.2M |
毛利率SLPSTRO
| Q4 25 | 59.1% | — | ||
| Q3 25 | 56.4% | — | ||
| Q2 25 | 64.0% | — | ||
| Q1 25 | 58.5% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 36.6% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 72.2% | — |
营业利润率SLPSTRO
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.8% | -499.9% | ||
| Q2 25 | -364.5% | -5.2% | ||
| Q1 25 | 12.1% | -393.8% | ||
| Q4 24 | 0.7% | -440.7% | ||
| Q3 24 | -6.2% | -797.2% | ||
| Q2 24 | 10.1% | -189.4% | ||
| Q1 24 | 24.3% | -435.0% |
净利率SLPSTRO
| Q4 25 | 3.7% | — | ||
| Q3 25 | -3.9% | -586.6% | ||
| Q2 25 | -330.6% | -18.0% | ||
| Q1 25 | 13.7% | -436.6% | ||
| Q4 24 | 1.1% | -489.2% | ||
| Q3 24 | 4.5% | -572.6% | ||
| Q2 24 | 16.9% | -186.8% | ||
| Q1 24 | 22.0% | -447.5% |
每股收益（稀释后）SLPSTRO
| Q4 25 | $0.03 | — | ||
| Q3 25 | $-0.03 | $-0.67 | ||
| Q2 25 | $-3.35 | $-0.14 | ||
| Q1 25 | $0.15 | $-0.91 | ||
| Q4 24 | $0.01 | $-27.63 | ||
| Q3 24 | $0.04 | $-0.59 | ||
| Q2 24 | $0.15 | $-0.59 | ||
| Q1 24 | $0.20 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.7M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $127.1M | $-132.5M |
| 总资产 | $137.8M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SLPSTRO
| Q4 25 | $35.7M | $141.4M | ||
| Q3 25 | $32.4M | $167.6M | ||
| Q2 25 | $28.4M | $205.1M | ||
| Q1 25 | $21.4M | $249.0M | ||
| Q4 24 | $18.2M | $316.9M | ||
| Q3 24 | $20.3M | $388.3M | ||
| Q2 24 | $119.0M | $375.6M | ||
| Q1 24 | $108.5M | $267.6M |
股东权益SLPSTRO
| Q4 25 | $127.1M | $-132.5M | ||
| Q3 25 | $124.8M | $-87.3M | ||
| Q2 25 | $123.8M | $-32.1M | ||
| Q1 25 | $189.5M | $-25.8M | ||
| Q4 24 | $184.7M | $44.6M | ||
| Q3 24 | $182.4M | $111.2M | ||
| Q2 24 | $180.9M | $152.2M | ||
| Q1 24 | $177.0M | $98.0M |
总资产SLPSTRO
| Q4 25 | $137.8M | $173.8M | ||
| Q3 25 | $131.9M | $209.7M | ||
| Q2 25 | $134.4M | $262.4M | ||
| Q1 25 | $201.4M | $321.4M | ||
| Q4 24 | $196.9M | $387.2M | ||
| Q3 24 | $196.6M | $451.8M | ||
| Q2 24 | $192.7M | $489.0M | ||
| Q1 24 | $194.0M | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.2M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 6.26× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SLPSTRO
| Q4 25 | $4.2M | $-177.2M | ||
| Q3 25 | $5.6M | $-38.2M | ||
| Q2 25 | $8.1M | $-44.7M | ||
| Q1 25 | $5.7M | $-67.9M | ||
| Q4 24 | $-1.3M | $-71.7M | ||
| Q3 24 | $1.7M | $-64.5M | ||
| Q2 24 | $5.7M | $9.5M | ||
| Q1 24 | $5.8M | $-64.7M |
自由现金流SLPSTRO
| Q4 25 | — | — | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $5.6M | — | ||
| Q4 24 | $-1.4M | — | ||
| Q3 24 | $1.6M | — | ||
| Q2 24 | $5.6M | — | ||
| Q1 24 | $5.4M | — |
自由现金流率SLPSTRO
| Q4 25 | — | — | ||
| Q3 25 | 30.5% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 25.0% | — | ||
| Q4 24 | -7.2% | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 30.0% | — | ||
| Q1 24 | 29.4% | — |
资本支出强度SLPSTRO
| Q4 25 | 0.0% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 2.4% | — |
现金转化率SLPSTRO
| Q4 25 | 6.26× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | -6.18× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 1.81× | — | ||
| Q1 24 | 1.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SLP
| Services Segment | $9.5M | 52% |
| Development | $7.2M | 39% |
| Discovery | $1.3M | 7% |
STRO
暂无分部数据
